激光光动力治疗真菌感染和新冠肺炎后毛霉菌病的疗效综述

Q4 Medicine

Journal of Cardiovascular Disease Research Pub Date : 2021-01-01 DOI:10.31838/jcdr.2021.12.03.62

C. Yavagal, Puja C. Yavagal, Soumya Sv, S. Sreedhar, S. Mangalekar, Madhu Hariharan

{"title":"激光光动力治疗真菌感染和新冠肺炎后毛霉菌病的疗效综述","authors":"C. Yavagal, Puja C. Yavagal, Soumya Sv, S. Sreedhar, S. Mangalekar, Madhu Hariharan","doi":"10.31838/jcdr.2021.12.03.62","DOIUrl":null,"url":null,"abstract":"Fungal infections are a major public health hazard that affect both healthy and immunocompromised people around the world. The Covid-19 pandemic is affecting Global Health and the worlds economy dramatically since early 2020. A significant number of COVID- 19 recovered patients are getting infected with fungal infections such as Mucormycosis. We do not seem to have enough resources and potent anti fungal medications to treat such patients. Similarities of fungi to mammalian cells have further led to difficulties in the development of new anti fungal drugs. Thus, there is a clear need for novel interventional strategies and innovative approaches to counter the mounting menace of opportunistic fungal infections in COVID recovered patients","PeriodicalId":15222,"journal":{"name":"Journal of Cardiovascular Disease Research","volume":"12 1","pages":"407-416"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Efficacy of laser photodynamic therapy on fungal infections and post COVID mucormycosis: a narrative review\",\"authors\":\"C. Yavagal, Puja C. Yavagal, Soumya Sv, S. Sreedhar, S. Mangalekar, Madhu Hariharan\",\"doi\":\"10.31838/jcdr.2021.12.03.62\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Fungal infections are a major public health hazard that affect both healthy and immunocompromised people around the world. The Covid-19 pandemic is affecting Global Health and the worlds economy dramatically since early 2020. A significant number of COVID- 19 recovered patients are getting infected with fungal infections such as Mucormycosis. We do not seem to have enough resources and potent anti fungal medications to treat such patients. Similarities of fungi to mammalian cells have further led to difficulties in the development of new anti fungal drugs. Thus, there is a clear need for novel interventional strategies and innovative approaches to counter the mounting menace of opportunistic fungal infections in COVID recovered patients\",\"PeriodicalId\":15222,\"journal\":{\"name\":\"Journal of Cardiovascular Disease Research\",\"volume\":\"12 1\",\"pages\":\"407-416\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cardiovascular Disease Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31838/jcdr.2021.12.03.62\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Disease Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31838/jcdr.2021.12.03.62","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

摘要

真菌感染是影响世界各地健康人群和免疫功能低下人群的主要公共卫生危害。自2020年初以来，新冠肺炎大流行对全球卫生和世界经济产生了巨大影响。相当多的COVID- 19康复患者感染了真菌感染，如毛霉病。我们似乎没有足够的资源和有效的抗真菌药物来治疗这些患者。真菌与哺乳动物细胞的相似性进一步导致了开发新的抗真菌药物的困难。因此，显然需要新的干预策略和创新方法来应对COVID康复患者中机会性真菌感染日益严重的威胁

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Efficacy of laser photodynamic therapy on fungal infections and post COVID mucormycosis: a narrative review

Fungal infections are a major public health hazard that affect both healthy and immunocompromised people around the world. The Covid-19 pandemic is affecting Global Health and the worlds economy dramatically since early 2020. A significant number of COVID- 19 recovered patients are getting infected with fungal infections such as Mucormycosis. We do not seem to have enough resources and potent anti fungal medications to treat such patients. Similarities of fungi to mammalian cells have further led to difficulties in the development of new anti fungal drugs. Thus, there is a clear need for novel interventional strategies and innovative approaches to counter the mounting menace of opportunistic fungal infections in COVID recovered patients

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Cardiovascular Disease Research Medicine-Cardiology and Cardiovascular Medicine

自引率

0.00%

发文量